Do we really need to spoon-feed AI anymore?

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The average daily trading volume for Recursion Pharmaceuticals (RXRX) is 6,882,906. The opening price for Recursion Pharmaceuticals today was 4.05.

FAC is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of FAC shares has increased $0.11 since the market last closed. This is a 2.52% ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. 1 tax payment and 1 sale were reported, with the sale representing $78,822.38 of the total.

At close: October 29 at 4:00:00 p.m. EDT ...